Translate
About
Abivax Sa (NASDAQ:ABVX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
Apr 1 2026
Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
Mar 23 2026
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Feb 21 2026
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Jan 7 2026
Abivax Provides 2026 Corporate Outlook
Financials
Revenue
$4.57 M
Market Cap
$9.38 B
EPS
-5.59